Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Glucagon degrading activity].

K Wakasugi1

  • 1Third Department of Internal Medicine, Yamagata University School of Medicine, Japan.

Nihon Naibunpi Gakkai Zasshi
|May 20, 1989
PubMed
Summary
This summary is machine-generated.

Glucagon degrading activity (GDA) in blood samples can interfere with radioimmunoassay (RIA) measurements. Proper sample handling, including adding EDTA and aprotinin, is crucial for accurate glucagon quantification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity.

Cell death & disease·2014
Same author

Change in environmental bacterial flora in a new hospital building.

The Journal of hospital infection·2009
Same author

Adenomatoid tumour of the liver.

Journal of clinical pathology·2008
Same author

Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.

European journal of clinical investigation·2007
Same author

The nutritional advantages of proximal gastrectomy for early gastric cancer.

Hepato-gastroenterology·2001
Same author

Guillain-Barré syndrome associated with herpes zoster.

Internal medicine (Tokyo, Japan)·2001

Area of Science:

  • Biochemistry
  • Endocrinology
  • Clinical Chemistry

Context:

  • Glucagon degrading activity (GDA) can affect the accuracy of glucagon measurements.
  • Radioimmunoassay (RIA) is a common method for quantifying glucagon levels.
  • Understanding factors influencing GDA is essential for reliable diagnostic testing.

Purpose:

  • To evaluate the impact of GDA on glucagon RIA.
  • To measure GDA in various blood components and patient samples.
  • To identify optimal sample handling procedures to minimize glucagon degradation.

Summary:

  • GDA levels vary in plasma, serum, red blood cells, and white blood cells.
  • EDTA and aprotinin significantly reduce GDA in plasma, while heparin increases it.
  • Elevated GDA was observed in patients with pancreas, liver, kidney diseases, and hyperthyroidism, normalizing after recovery.

Related Experiment Videos

  • Proper sample processing, including EDTA/aprotinin addition, rapid plasma separation, and cold storage, is recommended to prevent glucagon breakdown.

    • Impact:

    • Provides critical insights into pre-analytical variables affecting glucagon RIA.
    • Recommends specific sample handling protocols to improve assay accuracy.
    • Highlights the potential of GDA as a biomarker for certain diseases.
    • Contributes to more reliable glucagon level determination in clinical diagnostics.